Clinical

Dataset Information

0

Preventive effect of pregabalin on oxaliplatin-related neurotoxicity for patients with advanced/recurrent colorectal cancer: a prospective phase 2 study


ABSTRACT: Interventions: Pregabalin is administered during FOLFOX or XELOX therapy. Initial dose:75mg twice daily(150mg/day),increased to 300 - 600mg/day if there was persistent paresthesia or functional impariment(Grade2 or more). Primary outcome(s): Neurotoxicity frequency of accumulation dose 500mg/m2 of L-OHP (Grade2 or more) Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2624861 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2628289 | ecrin-mdr-crc
| 2617341 | ecrin-mdr-crc
2019-05-06 | GSE126786 | GEO
2023-04-04 | GSE228664 | GEO
2018-10-19 | PXD008993 | Pride
| PRJNA523238 | ENA
2013-01-29 | E-GEOD-35452 | biostudies-arrayexpress
2009-07-07 | GSE12018 | GEO
| PRJNA641207 | ENA
2018-10-24 | PXD007169 | Pride